tiprankstipranks

Alan Auerbach Insider Profile

11 Followers
Alan Auerbach, President & CEO, Director, Ten Percent Owner at Puma Biotechnology, holds 7.06M shares in Puma Biotechnology (Ticker: PBYI), holds ― shares in Radius Health (Ticker: ~RDUS).
tipranks
Alan Auerbach

Alan Auerbach
Puma Biotechnology (PBYI)
President & CEO, Director, Ten Percent Owner

Ranked #2,196 out of 100,202 Corporate Insiders

Profitable Transactions

62%
28 out of 45 Profitable Transactions

Average Return

+18.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$19M
100.00%
A breakdown of Alan Auerbach's holdings

Insider Roles

Puma Biotechnology
(PBYI)
President & CEO, Director, Ten Percent Owner
Roles that Alan Auerbach holds in companies

Most Profitable Insider Trade

Stock:
Puma Biotechnology
(PBYI)
Rating:Informative Sell
Date:Apr 03, 2019 - Apr 03, 2020
Return:+80.10%
The most profitable trade made by Alan Auerbach

Alan Auerbach's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Puma Biotechnology
Jul 18, 2024
President & CEO, Director, Ten Percent Owner
Uninformative Sell
81.10K
$19.42M
~RDUS
Radius Health
List of latest transactions for each holding click on a transaction to see Alan Auerbach's performance on stock

Alan Auerbach insider profile FAQ

What is the percentage of profitable transactions made by Alan Auerbach?
The percentage of profitable transactions made by Alan Auerbach is 62%.
    What is the average return per transaction made by Alan Auerbach?
    The average return per transaction made by Alan Auerbach is 18.20%.
      What stocks does Alan Auerbach hold?
      Alan Auerbach holds: PBYI, ~RDUS stocks.
        What was Alan Auerbach’s latest transaction?
        Alan Auerbach latest transaction was an Uninformative Sell of $81.10K.
          What was Alan Auerbach's most profitable transaction?
          Alan Auerbach’s most profitable transaction was an Informative Sell of PBYI stock on April 3, 2019. The return on the trade was 80.10%.
            What is Alan Auerbach's role in Puma Biotechnology?
            Alan Auerbach's role in Puma Biotechnology is President & CEO, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.